Mineralys Therapeutics, Inc. (MLYS) stock
MLYSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.78−0.70 (-4.83%)
Close on Nov 18, 2026Market cap $1.22BP/E –Yield –
Mineralys Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Mineralys Therapeutics's market cap was $1.43B on Nov 11, 2026, against $3.41B a year earlier. Over the last 4 years it ranged from $86.34M to $3.41B, with a median of $665.13M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.43B | -50.2% |
| 2025 | Dec 31, 2025 | $2.87B | +367.9% |
| 2024 | Dec 31, 2024 | $612.50M | +73.3% |
| 2023 | Dec 29, 2023 | $353.50M | – |
See a number that looks wrong?